GlassScriptPhysician profile
Kathryn Leyrer
NPI 1003576885
$919.19
in general payments reported to CMS, 2019-2025
15 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.78 · 2023: $71.00 · 2024: $266 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $158.52 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $152.14 | 2025 | Zoryve |
| Genzyme Corporation | $93.58 | 2022-2023 | |
| Glaxosmithkline, LLC. | $84.36 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $77.04 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $62.48 | 2024-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $60.97 | 2025 | |
| Abbvie INC. | $55.81 | 2023-2024 | |
| Novo Nordisk INC | $49.09 | 2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $24.46 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $23.27 | 2025 | Rexulti |
| Sun Pharmaceutical Industries INC. | $22.80 | 2022 | |
| Lundbeck LLC | $22.25 | 2025 | Rexulti |
| Lilly USA, LLC | $16.22 | 2025 | Kisunla |
| Inspire Medical Systems, INC. | $16.20 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Leyrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.